All Stories

  1. What is the place of naturalistic philosophy in the doing of science? Implications for the teaching of science
  2. The Climate Fix: make what’s important measurable …
  3. In the doing of science, what is the place for naturalistic philosophy? Implications for the teaching of science
  4. Occupation from a perspective of complementarity - Part 2 - Proposals for situating a complementarity perspective in occupational science
  5. Occupation from a perspective of complementarity - Part 1 - Background to the development of a concept
  6. A preliminary investigation of what occupational science is doing
  7. Restoring Australia’s long-term innovation requires investment in basic research
  8. “We Ourselves Are Both Actors and Spectators”: What is the Place of Naturalistic Philosophy in the Doing of Science? Implications for the Teaching of Science
  9. Review of: "Naturalism's maxims and its methods. Is naturalistic philosophy like science?"
  10. “Elements of My Life”
  11. Engineering indel and substitution variants of diverse and ancient enzymes using Graphical Representation of Ancestral Sequence Predictions (GRASP)
  12. Cat in Trinity Lane, Cambridge, 2010
  13. A Pair of Floating Microscopes: Transformation by Reflection
  14. A Left-Handed Pillar Box
  15. Antiinflammatory and Anticancer Properties of Grewia asiatica Crude Extracts and Fractions: A Bioassay-Guided Approach
  16. Lunar Eclipse, May 26, 2021
  17. Phytochemical Profile, Biological Properties, and Food Applications of the Medicinal Plant Syzygium cumini
  18. The Chemical Composition and Health-Promoting Effects of the Grewia Species—A Systematic Review and Meta-Analysis
  19. From Engineer to Artist: “Who Is the Potter, Pray, and Who the Pot?”
  20. Kookaburras on the Clothes Line, Backyard, Queensland
  21. In silico molecular dynamics of human glycophorin A (GPA) extracellular structure
  22. Syzygium cumini(L.),Skeels fruit extracts: In vitro and in vivo anti-inflammatory properties
  23. The interaction between Glycophorin A (GPA) and Band 3 in the formation of the Wright b (Wrb) antigen
  24. Tyrosinase inhibitors as potential antibacterial agents
  25. Hydroxyl substituted benzoic acid/cinnamic acid derivatives: Tyrosinase inhibitory kinetics, anti-melanogenic activity and molecular docking studies
  26. From Generation to Generation
  27. The Zone of Inhibition
  28. Serendipity in Science: The Unexpected Tie
  29. Discrimination and Social Justice: Questions of Diversity, Plurality, Representativeness, Measurability, and Doublespeak
  30. The Bay of Marseille, Viewed from L'Estaque, 2010
  31. Antimicrobial Silver in Medicinal and Consumer Applications: A Patent Review of the Past Decade (2007–2017)
  32. “Baby” Microscope
  33. Nicotiana tabacum, or the Letter “Aleph” with 22 Flowers
  34. Precision Medicines Have Faster Approvals Based On Fewer And Smaller Trials Than Other Medicines
  35. A Shark–Human Chimera
  36. Development of a Multiplexed Microsphere PCR for Culture-Free Detection and Gram-Typing of Bacteria in Human Blood Samples
  37. Evolution of the magic bullet: Single chain antibody fragments for the targeted delivery of immunomodulatory proteins
  38. Human Blood CD1c+ Dendritic Cells Promote Th1 and Th17 Effector Function in Memory CD4+ T Cells
  39. A New Clade of Insect-Specific Flaviviruses from Australian Anopheles Mosquitoes Displays Species-Specific Host Restriction
  40. Characterization of the banana streak virus capsid protein and mapping of the immunodominant continuous B-cell epitopes to the surface-exposed N terminus
  41. Permeation of topically applied Magnesium ions through human skin is facilitated by hair follicles
  42. A New Orbivirus Isolated from Mosquitoes in North-Western Australia Shows Antigenic and Genetic Similarity to Corriparta Virus but Does Not Replicate in Vertebrate Cells
  43. CMRF-56+ blood dendritic cells loaded with mRNA induce effective antigen-specific cytotoxic T-lymphocyte responses
  44. Discovery and characterisation of a new insect-specific bunyavirus from Culex mosquitoes captured in northern Australia
  45. Commensal Viruses of Mosquitoes: Host Restriction, Transmission, and Interaction with Arboviral Pathogens
  46. The Tortoise and the Hare: Evolving Regulatory Landscapes for Biosimilars
  47. A novel insect-specific flavivirus replicates only in Aedes-derived cells and persists at high prevalence in wild Aedes vigilax populations in Sydney, Australia
  48. Immunosuppressive human anti-CD83 monoclonal antibody depletion of activated dendritic cells in transplantation
  49. RNA and DNA Diagnostics on Microspheres: Current and Emerging Methods
  50. Genotyping of Campylobacter jejuni using a novel Polymerase-Chain-Reaction-Microsphere approach
  51. Application of the PrimRglo Assay Chemistry to Multiplexed Bead Assays
  52. Effects of magnesium deficiency – More than skin deep
  53. Multi-locus sequence typing of Campylobacter jejuni using a novel polymerase-chain-reaction-microsphere method
  54. Interdisciplinary science research and education
  55. Gene expression phenotypes for lipid metabolism and intramuscular fat in skeletal muscle of cattle1
  56. A New, Multiplex, Quantitative Real-Time Polymerase Chain Reaction System for Nucleic Acid Detection and Quantification
  57. Multiplex–microsphere–quantitative polymerase chain reaction: Nucleic acid amplification and detection on microspheres
  58. Recombinant Vaccines: Development, Production, and Application
  59. PrimRglo: A multiplexable quantitative real-time polymerase chain reaction system for nucleic acid detection
  60. Chronic exposure to anabolic steroids induces the muscle expression of oxytocin and a more than fiftyfold increase in circulating oxytocin in cattle
  61. Expecting the unexpected: nucleic acid-based diagnosis and discovery of emerging viruses
  62. Chapter 2 Complexity and mastery in shaping interdisciplinarity
  63. Molecular Phylogeny of Edge Hill Virus Supports its Position in the Yellow Fever Virus Group and Identifies a New Genetic Variant
  64. Recombinant vaccines
  65. A method for rapid, ligation-independent reformatting of recombinant monoclonal antibodies
  66. Detection of Influenza A Virus Neuraminidase and PB2 Gene Segments by One Step Reverse Transcription Polymerase Chain Reaction
  67. University biotechnology education in Australia in an international context
  68. A broad spectrum, one-step reverse-transcription PCR amplification of the neuraminidase gene from multiple subtypes of influenza A virus
  69. Genomic characterisation of Wongabel virus reveals novel genes within the Rhabdoviridae
  70. Universal primers that amplify RNA from all three flavivirus subgroups
  71. Interdisciplinarity and Interprofessionalism: Implications for Biotechnology Education
  72. Use of Chimeric Antibodies as Positive Controls in an Enzyme-Linked Immunosorbent Assay for Diagnosis of Scrub Typhus (Infection by Orientia tsutsugamushi)
  73. Reply to Herrera and Ruiz-Opazo's letter published in the June 2006 issue
  74. A1079T transversion in the gene for the α1 isophorm of the Na+/K+ ATPase in the Dahl S rat
  75. Development of an Oligonucleotide-Based SNP Detection Method on Lateral Flow Strips Using Hexapet Tags
  76. Chimerization of multiple antibody classes using splice overlap extension PCR
  77. The ''parallel bridge'' and its relevance to biotechnology new ventures
  78. Towards definition of the global biotechnology value chain using cases from Australian biotechnology SMEs
  79. Valuing of firms' prior knowledge: a measure of knowledge distance
  80. Arsenic inhibits the repair of DNA damage induced by benzo(a)pyrene
  81. Placental Growth Hormone Is Not Suppressed by Oral Glucose Loading in Normal Human Pregnancy
  82. Neither the New Zealand Genetically Hypertensive Strain nor Dahl Salt-Sensitive Strain Has an A1079T Transversion in the α1 Isoform of the Na + ,K + -ATPase Gene
  83. Growth hormone binding protein in normal and aneuploid pregnancy: a paradoxical decrease in trisomy 18
  84. Growth hormone binding protein in normal and aneuploid pregnancy: a paradoxical decrease in trisomy 18
  85. Comparison of Competitively Primed and Conventional Allele-Specific Nucleic Acid Amplification
  86. Placental Growth Hormone (GH), GH-Binding Protein, and Insulin-Like Growth Factor Axis in Normal, Growth-Retarded, and Diabetic Pregnancies: Correlations with Fetal Growth
  87. True
  88. Administration of growth hormone or IGF-I to pregnant rats on a reduced diet throughout pregnancy does not prevent fetal intrauterine growth retardation and elevated blood pressure in adult offspring
  89. Bcl-2 genes and growth factors in the pathology of ischaemic acute renal failure
  90. Growth hormone binding protein correlates strongly with leptin and percentage body fat in GH-deficient adults, is increased by GH replacement but does not predict IGF-I response
  91. Analysis and Application of an Equilibrium Model forin vitroBioassay Systems with Three Components: Receptor, Hormone and Hormone-Binding-Protein
  92. Expression of Growth Hormone Receptors by Lymphocyte subpopulations in the Human tonsil
  93. Growth Hormone-Binding Protein in Normal and Pathologic Gestation: Correlations with Maternal Diabetes and Fetal Growth1
  94. Functional growth hormone (GH) receptors and GH are expressed by preimplantation mouse embryos: A role for GH in early embryogenesis?
  95. The serum growth hormone binding protein: pregnant with possibilities
  96. Human growth hormone fragments 1-43 and 44-191: in vitro somatogenic activity and receptor binding characteristics in human and nonprimate systems
  97. Upregulation of GH receptor and GH binding protein during pregnancy in the GH deficient rat
  98. A Growth Hormone Agonist Produced by Targeted Mutagenesis at Binding Site 1.
  99. Measurement of growth hormone-binding protein in the rat by a ligand immunofunctional assay
  100. Control of growth hormone (GH) binding protein release from human hepatoma cells expressing full-length GH receptor.
  101. Evidence for Involvement of the Carboxy Terminus of Helix 1 of Growth Hormone in Receptor Binding: Use of Charge Reversal Mutagenesis to Account for Calcium Dependence of Binding and for Design of Higher Affinity Analogs
  102. Selective inhibition of mouse placental lactogen II secretion by tumour necrosis factor-α
  103. Signal Transduction by the Growth Hormone Receptor
  104. The search for receptor-interactive regions in growth hormone: historical perspectives and novel strategies
  105. Expression of growth hormone-binding protein with a hydrophilic carboxyl terminus by the mouse placenta: studies in vivo and in vitro
  106. Growth hormone receptor and growth hormone-binding protein messages in mouse placenta contain the exon analogous to human exon 3
  107. Localization and ontogeny of growth hormone receptor gene expression in the central nervous system
  108. A strategy for optimizing charge reversal mutagenesis of ion pairs in hormone—receptor or enzyme—substrate complexes
  109. The first disulphide loop of the rabbit growth hormone receptor is required for binding to the hormone
  110. Expression of the growth hormone receptor and growth hormone-binding protein during pregnancy in the mouse
  111. A mouse growth hormone-binding protein RIA: concentrations in maternal serum during pregnancy.
  112. Growth Hormone (GH) Receptors in Clonal Osteoblast Like Cells Mediate a Mitogenic Response to GH*
  113. Visual Demonstration of Growth Hormone Receptors on Human Growth Plate Chondrocytes*
  114. Soluble forms of the rabbit adipose tissue and liver growth hormone receptors are antigenically identical, but the integral membrane forms differ
  115. Characterization of the growth hormone-binding protein of human serum using a panel of monoclonal antibodies
  116. An electrostatic model for the interaction between growth hormone and its receptor involving chelation of Ca2+ to the human growth hormone molecule
  117. The Ontogeny of Growth Hormone Receptors in the Rabbit Tibia*
  118. Use of calcium dependence as a means to study the interaction between growth hormones and their binding proteins in rabbit liver
  119. Growth hormone receptor and serum binding protein: purification, cloning and expression
  120. Serum and liver cytosolic growth-hormone-binding proteins are antigenically identical with liver membrane ‘receptor’ types 1 and 2
  121. Evidence for Differential Binding of Growth Hormones to Membrane and Cytosolic GH Binding Proteins of Rabbit Liver
  122. Evidence from the use of monoclonal antibody probes for structural heterogeneity of the growth hormone receptor
  123. Monoclonal Antibodies to the Rabbit Liver Growth Hormone Receptor: Production and Characterization*
  124. Use of serum copper/zinc ratio in patients with large bowel cancer
  125. Tennessee antigen
  126. Tennessee antigen
  127. Serum glycoproteins in diagnosis and monitoring of patients with large-bowel cancer
  128. VALUE OF SERIAL CARCINOEMBRYONIC ANTIGEN DETERMINATIONS FOR EARLY DETECTION OF RECURRENT CANCER